Autoantibodies against type I IFNs in patients with life-threatening COVID-19
2020 · Science · 2,815 citations
https://doi.org/10.1126/science.abd4585
A
Alexandre Bélot
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
468
Papers
22.4K
Citations
62
h-index
190
i10-index
Alexandre Bélot is an academic researcher from Université Claude Bernard Lyon 1. The author has contributed to research in topics: Autoimmune and Inflammatory Disorders Research & Inflammasome and immune disorders & Systemic Lupus Erythematosus Research. The author has an h-index of 62, co-authored 398 publications.
ORCID: 0000-0003-4902-5332Papers by this author
worksAutoantibodies against type I IFNs in patients with life-threatening COVID-19
2020 · Science · 2,815 citations
https://doi.org/10.1126/science.abd4585
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
2020 · Science · 2,377 citations
https://doi.org/10.1126/science.abd4570
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
2021 · Science Immunology · 617 citations
https://doi.org/10.1126/sciimmunol.abl4340
Idiopathic inflammatory myopathies and the lung
2015 · European Respiratory Review · 188 citations
https://doi.org/10.1183/16000617.00002015
Early-onset autoimmunity associated with SOCS1 haploinsufficiency
2020 · Nature Communications · 142 citations
https://doi.org/10.1038/s41467-020-18925-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat